Page last updated: 2024-08-21

medroxyprogesterone and Cancer of Head

medroxyprogesterone has been researched along with Cancer of Head in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amadori, D; Falcini, F; Flamini, E; Frassineti, GL; Maltoni, M; Nanni, O; Piccinini, C; Riccobon, A1

Trials

1 trial(s) available for medroxyprogesterone and Cancer of Head

ArticleYear
Clinical and laboratory evaluation of the myeloprotective effect of medroxyprogesterone acetate in head and neck cancer.
    European journal of cancer (Oxford, England : 1990), 1992, Volume: 28A, Issue:8-9

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cell Count; Cisplatin; Fluorouracil; Granulocytes; Head and Neck Neoplasms; Hematopoietic Stem Cells; Humans; Macrophages; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Methotrexate; Mitosis; Vincristine

1992